Takeshi Shirayama

Takeshi Shirayama

Auto-generated profile, based on publicly available information

Takeshi Shirayama

Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2013 in Heart Rhythm
Verified
Journal Article
Closed access
PDF file
MFMegumi Fukuyama
Megumi Fukuyama
SOSeiko Ohno
Seiko Ohno
QWQi Wang
Qi Wang
TSTakeshi Shirayama
Takeshi Shirayama
HIHIDEKI ITOH
HIDEKI ITOH
MHMinoru Horie
Minoru Horie

11 November 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KYKenji Yanishi
Kenji Yanishi
TNTakeshi Nakamura
Takeshi Nakamura
NNNaohiko Nakanishi
Naohiko Nakanishi
IYIsao Yokota
Isao Yokota
KZKan Zen
Kan Zen
SMSatoaki Matoba
Satoaki Matoba
Many mortality risk scoring tools exist among patients with ST-elevation Myocardial Infarction (STEMI). A risk stratification model that evaluates STEMI prognosis more simply and rapidly is preferred in clinical practice. We developed a simple stratification model for blood examination by using the STEMI data of AMI-Kyoto registry in the derivation set (n = 1,060) and assessed its utility for mortality prediction in the validation set (n = 521). We selected five variables that significantly worsen in-hospital mortality: white blood cell count, hemoglobin, C-reactive protein, creatinine, and blood sugar levels at >10,000/μL, 1.0 mg/dL, >1.0 mg/dL, and >200 mg/dL, respectively. In the derivation set, each of the five variables significantly worsened in-hospital mortality (p < 0.01). We developed the risk stratification model by combining laboratory variables that were scored based on each beta coefficient obtained using multivariate analysis and divided three laboratory groups. We also found a significant trend in the in-hospital mortality rate for three laboratory groups. Therefore, we assessed the utility of this model in the validation set. The prognostic discriminatory capacity of our laboratory stratification model was comparable to that of the full multivariable model (c-statistic: derivation set vs validation set, 0.81 vs 0.74). In addition, we divided all cases (n = 1,581) into three thrombolysis in myocardial infarction (TIMI) risk index groups based on an In TIME II substudy; the cases were further subdivided based on this laboratory model. The high laboratory group had significantly high in-hospital mortality rate in each TIMI risk index group (trend of in-hospital mortality; p < 0.01). This laboratory stratification model can predict in-hospital mortality of STEMI simply and rapidly and might be useful for predicting in-hospital mortality of STEMI by further subdividing the TIMI risk index.

1 January 2004 in Circulation Journal
Verified
Journal Article
Open access
NUNorifumi Urao
Norifumi Urao
HSHirokazu Shiraishi
Hirokazu Shiraishi
KIKazuya Ishibashi
Kazuya Ishibashi
MHMasayuki Hyogo
Masayuki Hyogo
MTMasaki Tsukamoto
Masaki Tsukamoto
MNMasao Nakagawa
Masao Nakagawa
A patient with idiopathic long QT syndrome had repeated syncopal episodes. The QTc interval on the electrocardiogram at rest was 530 ms and was prolonged by exercise up to 740 ms with T wave alternation. Intravenous epinephrine (0.1 microg/kg weight per min), but not isoproterenol (0.7 microg/min), produced early after depolarization of the monophasic action potential recorded at the right ventricular apex. Epinephrine prolonged the QTc interval to 710 ms. After the addition of propranolol to the epinephrine, the QTc (580 ms) was longer than at baseline. Methoxamine also prolonged the QTc to 580 ms. The QT interval in long QT syndrome is generally considered to be prolonged by a beta-adrenergic effect, but in the present case alpha-adrenergic stimulation had an additional effect on the prolongation of the QT interval.

1 January 2000 in Internal Medicine
Verified
Journal Article
Open access
PDF file
HSHirokazu Shiraishi
Hirokazu Shiraishi
TSTakeshi Shirayama
Takeshi Shirayama
KIKeiji Inoue
Keiji Inoue
HTHiroyuki Tanaka
Hiroyuki Tanaka
HKHiroomi Kuwabara
Hiroomi Kuwabara
MNMasao Nakagawa
Masao Nakagawa
Myotonic dystrophy (MD) is characterized by myotonia and muscular dystrophy and cardiac involvement with tachy-arrhythmia is rarely encountered. We report a case of MD complicated with severe left ventricular hypofunction and incessant ventricular tachycardia (VT) with varying heart rates. The morphology of VT suggested that it originated from the right ventricular outflow tract, and electrophysiological study disclosed that the mechanism of VT was abnormal automaticity. Catheter ablation was performed to treat this VT. The patient had a cardiomyopathy with normal coronary arteries. The specimen of RV biopsy showed moderate hypertrophy, mild fat infiltration and slight fibrosis. These findings are histologically consistent with myotonic dystrophy. (Internal Medicine 39: 39-44, 2000)

1 December 1991 in Heart and Vessels
Verified
Journal Article
Closed access
PDF file
IOItsuki Omori
Itsuki Omori
DIDaisuke Inoue
Daisuke Inoue
TSTakeshi Shirayama
Takeshi Shirayama
JAJun Asayama
Jun Asayama
HKHiroshi Katsume
Hiroshi Katsume
MNMasao Nakagawa
Masao Nakagawa

24 September 2004 in Pacing and Clinical Electrophysiology
Verified
Journal Article
Closed access
PDF file
Hiroki ManiHiroki Mani
Hiroki Mani
TSTakeshi Shirayama
Takeshi Shirayama
YSYoko Suzaki
Yoko Suzaki
TSTomohiko Sakatani
Tomohiko Sakatani
TSTakashi Sakamoto
Takashi Sakamoto
MTMasafumi Taniwaki
Masafumi Taniwaki